BAA contract- FY26C2AP9 advanced CMC index and intelligence platform for drug quality control, shortage prediction, and strategic reshoring
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00069
- Awardee
-
National Institute For Pharmaceutical Technology & Education Inc. UEI RKVKGV1CJDB8
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $634,642
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 100% obligated
- $634,642.00 Current and potential, with all options
- Completion date 8% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55414, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $634,642 definitive contract to National Institute For Pharmaceutical Technology & Education Inc. (doing business as Nipte) for an advanced CMC index and intelligence platform for drug quality control, shortage prediction, and strategic reshoring on September 30, 2026, under a no-set-aside BAA mechanism.
The award derives from the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which seeks extramural research proposals to advance regulatory science across FDA-regulated domains. The solicitation, posted November 21, 2025 with amendments through January 16, 2026, operates under FAR 6.102(d)(2) and 35.016 and prioritizes modernizing development and evaluation of FDA-regulated products, strengthening post-market surveillance and labeling, and invigorating public health preparedness. The opportunity is classified under NAICS 541714 (Research and Development in Biotechnology) and PSC code AJ11 (General Science and Technology R&D Services). Place of performance is Minneapolis, MN 55414. The contract is firm fixed price with an ultimate completion date of September 29, 2027.
Quick answers
Who was awarded contract 75F40126C00069?
75F40126C00069 was awarded to National Institute For Pharmaceutical Technology & Education Inc. by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00069 worth?
The government has obligated $634,642 on 75F40126C00069.
Was contract 75F40126C00069 competed?
The extent of competition for 75F40126C00069 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award